Cardiol Therapeutics CRDL Ratios (2020-2026)

NASDAQ CRDL
$1.86 -0.10 (-5.12%)
At close: Aug 20, 2026 · 1:56 PM UTC
Ratios Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-8,123.20%
EBIT Margin (Quarter)
-8,155.55%
EBITDA Margin (Quarter)
-8,113.00%
Operating Margin (Quarter)
-8,155.55%
Net Margin (Quarter)
-8,123.20%
FCF Margin (Quarter)
-7,711.23%
Efficiency
Assets Average (Quarter)
27.55M47.46M66.21M60.48M55.33M49.06M42.33M37.04M33.61M29.54M25.03M21.17M16.04M17.83M20.27M16.06M11.90M13.17M19.92M
Invested Capital (Quarter)
3.95M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-50.83-59.88
Times Interest Earned (Quarter)
-50.83-59.88
Valuation
Enterprise Value (Quarter)
-26.62M-22.76M-66.56M-59.09M-55.26M-50.25M-43.81M-36.59M-33.46M-30.24M-25.66M-21.20M-17.56M-11.64M-21.89M-16.23M-13.13M-8.45M-15.36M-20.18M
Return Ratios
Return on Capital Employed (Quarter)
-108.87%-80.41%-53.99%-64.84%-74.05%-76.03%-179.09%-194.64%-175.85%
Return on Assets (Quarter)
-0.01%-0.01%0.00%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Sales (Quarter)
-0.81%